#FORTIS buy above 265 252 Positional TGT 270,275, 280+

#FORTIS will declare results on Feb 11, 2022 Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.

BUDGET 2022 & HEALTHCARE – A STORY OF MISSED EXPECTATIONS? After a 137% YoY increase in allocation, hopes for the healthcare sector with respect to the Budget remained high amidst a resurging COVID-19 crisis, remained rather high. However, reactions to the actual budget proposals and allocations, have been…mixed, to say the least. WHAT THE BUDGET PROMISED? What can be termed as the most novel of the proposals in this sector lies in the government’s path-breaking move of introducing the Ayushman Bharat Digital Mission in the budget with the objective of ensuring universal access to healthcare facilities, across the country from a long-run perspective. However, on the opposite end of the spectrum, the government’s biggest miss lay in the fact that there were absolutely no policy amendments facilitating the participation on the part o the private players with the express objective of providing an impetus in strengthening the country-wide healthcare infrastructure as well as alleviate the immediate healthcare-services-access dilemma. A second aspect of the Healthcare budget that has hogged the limelight has been the focus on Mental Health & Digitisation, with large scale allocation to a National-Tele Mental Health programme as well as an open platform for the national digital health ecosystem consisting of digital registries of health providers and health facilities, unique health identity and universal access to health facilities WHAT IT SHOULD/COULD HAVE PROMISED? In terms of the impact that we can expect due to the budget outlay in this sector, we must take a look at the government’s extension of benefit of the concessional tax regime, applicable to manufacturing companies. Denoting the pharmaceutical sector as one of the sunrise opportunity sectors, the government plans to ensure that the sector should receive its fair share of benefit from future supportive policies. While this sounds well in theory and at an oratory level there have been no moves in consideration to the long-standing demand/expectation of industry to incentivise research and development needed to enable India to move from being an incremental innovator to becoming a global player in innovative drugs. On a different front, we see that the budget outlay for public-hospitals has increased by 30%, but along the same lines, the much-needed investment for strengthening the surveillance system has seen only a mere 16.4 % increase. The Ayushman Bharat health insurance scheme remains to be grossly underfunded and allocated the same amount as last year. Again a 3.92% increase in healthcare research has led to further disappointments, while the need to build further laboratories out of this budget looms over the industry and prospects of additional funding-aid from the World Bank or ADB in the near horizon, looks bleak. CONCLUSION: The 2022 Budget could have been a landmark year in the healthcare front, empowering the country to develop the resilience required to so that we never go through the disruptions we have witnessed. Sadly, it did little towards bridging the gaps in the system, as we stick to the healthcare expense still being at 1.5% of the GDP. #FORTIS #APOLLOHOSP #GLAND

#FORTIS What a journey. From 155 To 300. In One YEAR.

#FORTIS Book 100% Gains In FORTIS

SWING trade stock @ FORTIS 👉Buy At 267-272( do not buy all quantity at same level, try to accumulate on dip) 👉TGT 293/296/300+, sl at 254 (on closing basis) SWING trade(time 1-2 weeks)* Do not use more than 10-15% of capital* Educational purposes* #FORTIS

FORTIS 300+ 100% returns in 8 months..👍🏻🙏🏻 Enjoy. #FORTIS

Who wants next FORTIS ? #FORTIS

Fortis 290+ #FORTIS

Fortis 280+ #FORTIS

Buy #FORTIS HEALTHCARE around 233 (+/- 10) Target(s) : 266, 280 Stop loss: / as per your comfort Calls are for educational purpose only. Strongly recommend to do your own Analysis before investing. Tracks of all my free calls in my Telegram channel & info on my free webinars also

56% Returns In 6 Months. More To COME. Time It If You Can #FORTIS

Happy New Year FORTIS 244+ #FORTIS

225+ 46% up from buying #FORTIS

Fortis 219+ Book 50% #FORTIS

212 #FORTIS

FORTIS 205 #FORTIS

Fortis 201 🤗🥳 Only Jackpot Trades 🤗🥳 #FORTIS

FORTIS 188.8 🤗🥳 KEEP HOLDING 🤗🥳 #FORTIS

FORTIS 178+ 🤗🥳 #FORTIS

Fortis 180+ 🤗🥳💚 17% up from the buying levels 🤗🥳 #FORTIS

Fortis 175+ 13% up from the buying recommendation in just one week. HOLD #FORTIS

Fortis is my biggest bet of 2021 as of now..🤗🥳 #FORTIS

Fortis 169 🤗🥳 10% up from our buying price..🤗🥳 HOLD Wait for my EXIT Call. #FORTIS

Multibagger Stock Idea Or New Year Gift From My Side To You Guys: Buy Fortis Healthcare at CMP and at every dips in next 1-2 months And hold it for 18 months. Target - 350 🥳🤑 #FORTIS

CNBC-TV18's top stocks to watch #ADANIGREEN #SRTRANSFIN #FILATEX #FDC #FORTIS 31/12/2020 Thursday Expiry Weekly Expiry Monthly Expiry Qtrly Expiry Yearly Expiry Decade Expiry Best of all: 2020 also will get expired! Lost many good people this year!! Wish you all stay positive & test negative!! http://www.cnbctv18.com/photos/market/stocks/cnbc-tv18s-top-stocks-to-watch-out-for-on-december-31-adani-green-energy-shriram-transport-finance-ansal-properties-infrastructure-fortis-healthcare-fdc-7863381.htm

Stocks in the news Shriram Transport Finance: The company approved and allotted senior secured rated, listed redeemable NCD of the face value of Rs 10 lakh each on a private placement basis. Filatex India: The company's proposed installation of captive rooftop solar power generation of 1.0 MW at Dahej and 0.4 MW at Dadra has been successfully completed and commenced commercial operation w.e.f. 30th December 2020. Sangam India: Company board approved allotment of 40 lakh equity shares at a price of Rs 50 per equity shares aggregating to Rs 20 crore. FDC: The company to expand its production capacity by the installation of an additional BFS machine. Fortis Healthcare: ICRA upgraded the long-term rating for the line of credit of the company's subsidiaries- SRL Limited and SRL Diagnostics Private Limited. Electrotherm (India): The company said it defaulted on the payment of the term loan & working capital loan of Rs 0.62 crore on November 30. Ortin Laboratories: NCLT sanctioned the scheme of arrangement between Ortin Laboratories and Vineet Laboratories and their respective shareholders and creditors. #SRTRANSFIN #FDC #FILATEX #ORTINLABSS #FORTIS

Stocks in the news Auto Stocks including M&M, Tata Motors, Bajaj Auto, Maruti Suzuki, TVS Motor, Hero MotoCorp and Ashok Leyland in focus: Companies will release their November sales data. Hero Motocorp: The company appointed Michael Clarke as chief operating officer. Future Consumer: Bennett, Coleman & Company reduced stake in the company to 4.25 percent from 6.33 percent via open market transaction. HealthCare Global Enterprises: The company entered into a Share Purchase Agreement with Kamini A Rao and her family members (minority shareholders) for the acquisition of 46,695 Equity Shares aggregating to 49.9 percent in BACC. The company approved the appointment of Meghraj Arvindrao Gore as the CEO. ICICI Lombard General Insurance Company: The company received in-principle approval of The Insurance Regulatory and Development Authority of India to the draft scheme of arrangement between the company and Bharti AXA General Insurance Company. Fortis Healthcare: Aberdeen Standard Investments (Asia) Ltd increased its stake in the company to 5.02 percent from 4.96 percent via open market purchases. #NIFTYAUTO #ICICIGI #FORTIS #FCONSUMER

BUZZ-India's Fortis Healthcare hits 1-1/2-year high on Q2 profit - Reuters News 07-Nov-2019 12:26:58 PM ** Shares of Fortis Healthcare FOHE.NS rise as much as 5.2% to 154.40 rupees, their highest sinc